Thank you to our speakers, sponsors, and delegates who joined us for the summit! If you are interested in the 2023 event, please get in touch at

ild image

Trouble downloading the brochure?
Request a copy here

Your Top 5 Takeaways From Key Stakeholders:

  • Uncover the clinical research propelling ILD drug development forwards in 2022 with Boehringer Ingelheim and Novartis to further
  • Investigate emerging ILD therapeutic approaches with Saje Pharma and Pieris Pharmaceuticals
  • Discover how pneumoproteitns and cytokines can be used to strategically enrich SSc-ILD clinical trials with The University of Texas
  • Examine inflammatory interstitial lung disease from a drug development perspective with Pfizer
  • Deep dive into the lumping versus splitting debate in the context of disease progression with McMaster University